| Literature DB >> 32537035 |
Ee Ling Siew1, Ahmad Faizzudin Farris2, Noramiwati Rashid1, Kok Meng Chan3,4, Nor Fadilah Rajab1,2,5.
Abstract
BACKGROUND: Rare earth minerals of the lanthanide series are widely used in the field of medical and clinical application. Gadolinium (Gd), the most preferred rare earth mineral is frequently used as magnets, superconductors and magnetic resonance imaging (MRI) contrast agent. Increasing production of gadolinium waste, known potent toxicity of this element and lack of information on its Material Safety Data Sheet (MSDS) prompts health risk assessment on gadolinium. In this study, cytotoxicity and genotoxicity of Gadolinium (III) chloride (GdCl3) were investigated using MTT assay, Alkaline Comet assay and Micronucleus assay, respectively.Entities:
Keywords: Clastogenicity; Cytotoxicity; DNA damage; Gadolinium (III) chloride
Year: 2020 PMID: 32537035 PMCID: PMC7288472 DOI: 10.1186/s41021-020-00161-3
Source DB: PubMed Journal: Genes Environ ISSN: 1880-7046
Fig. 1Cytotoxicity of GdCl3 against V79–4 cells with 24 h of incubation. The results are expressed as mean ± SE of at least three independent experiment. *Significant difference (p < 0.05) as compared to negative control
Level of DNA damage on V79–4 treated cell line without metabolic activation. The results are the means ±SE of at least three separate experiments (*p < 0.05 versus negative control)
| Level of DNA damage (Arbituary unit) | ||
|---|---|---|
| Negative control | 0.31 ± 0.08 | 2.90 ± 0.63 |
| 0.25 mM GdCl3 | 0.65 ± 0.16 | 4.69 ± 1.08 |
| 0.5 mM GdCl3 | 0.44 ± 0.19 | 4.27 ± 1.24 |
| 1.0 mM GdCl3 | 1.05 ± 0.14 | 7.04 ± 0.90 |
| Positive control | *7.92 ± 0.49 | *32.42 ± 2.34 |
| Negative control | 0.60 ± 0.07 | 5.11 ± 0.57 |
| 0.25 mM GdCl3 | 0.77 ± 0.20 | 6.49 ± 1.62 |
| 0.5 mM GdCl3 | 0.39 ± 0.03 | 3.75 ± 0.12 |
| 1.0 mM GdCl3 | 1.24 ± 0.31 | 8.85 ± 1.93 |
| Positive control | *6.00 ± 0.81 | *29.49 ± 3.38 |
Level of DNA damage on V79–4 treated cell line with metabolic activation. The results are the means ±SE of at least three separate experiments (*p < 0.05 versus negative control)
| Level of DNA damage (Arbituary unit) | ||
|---|---|---|
| Negative control | 0.42 ± 0.12 | 3.46 ± 0.72 |
| Negative control + S9 | 0.47 ± 0.09 | 3.80 ± 0.66 |
| 0.25 mM GdCl3 | 0.61 ± 0.06 | 4.70 ± 0.30 |
| 0.5 mM GdCl3 | 0.98 ± 0.07 | 6.93 ± 0.34 |
| 1.0 mM GdCl3 | 0.54 ± 0.08 | 3.81 ± 0.63 |
| Positive control | *6.87 ± 0.88 | *26.40 ± 2.14 |
| Negative control | 0.42 ± 0.12 | 3.44 ± 0.45 |
| Negative control + S9 | 0.66 ± 0.02 | 5.31 ± 0.50 |
| 0.25 mM GdCl3 | 1.15 ± 0.2 | 7.25 ± 1.25 |
| 0.5 mM GdCl3 | 0.97 ± 0.24 | 6.83 ± 1.46 |
| 1.0 mM GdCl3 | 1.32 ± 0.04 | 7.48 ± 0.47 |
| Positive control | *6.87 ± 0.88 | *26.40 ± 2.14 |
Fig. 2Percentage of micronucleus, RICC and RPD, in V79–4 cells induced by GdCl3 and positive control (Mitomycin C) following (a) 3 h, b 24 h without metabolic activation. The results are the means ±SE of at least three separate experiments (*p < 0.05 versus negative control)
Fig. 3Percentage of micronucleus, RICC and RPD, in V79–4 cells induced by GdCl3 and positive control (Cyclophosphamide) following 3 h with metabolic activation. The results are the means ±SE of at least three separate experiments (*p < 0.05 versus negative control)